Share

October 2015; 5 (5) Clinical and Ethical Challenges

Recognizing and reducing cognitive bias in clinical and forensic neurology

Saty Satya-Murti, Joseph Lockhart
First published September 24, 2015, DOI: https://doi.org/10.1212/CPJ.0000000000000181
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
293

Share

Article Information

vol. 5 no. 5 389-396
DOI: 
https://doi.org/10.1212/CPJ.0000000000000181
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published September 24, 2015.

Article Versions

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Saty Satya-Murti, MD and
    2. Joseph Lockhart, PhD, ABPP
  1. Saty Satya-Murti, MD and
    2. Scientific Advisory Boards:

    1. Between January 2013 and July 2015 I have participated in telephone consultations and/or in-person Medical Advisory Board meetings for: (1)Evidera (formerly United BioSource Corporation UBC)(2)Simon-Kucher consultants (3) Covidien (4) Baxter (5) Shire (6) Stratas Consultants,(7)AstraZeneca (8)Avalere LLC, (9)AbioMed, and(10) 1798 Consultants

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expenses: (1)United BioSource Corporation UBC (2010-13)(2)AstraZeneca (3)Avalere LLC, (4) Evidera consulting group, (5) Covidien, (6) Michael J. Fox Foundation, (7) Foley Hoag LLP, (8) Baxter

    Editorial Boards:

    1. Neurology: Clinical Practice Editorial Board Member. Appointed in early 2014.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Panelist, and later (2010-2011) Vice-Chair CMS-Medcac (Medicare Evidence Development and Coverage Advisory Committee). For the duration of the Medcac meeting, usually 1-2 days, I was considered an SGE (Special Government Employee).

    Consultancies:

    1. Commercial:(1)Evidera (formerly United BioSource Corporation UBC)(2)Simon-Kucher consultants (3) Covidien (4) Baxter (5) Shire (6) Stratas Consultants,(7)AstraZeneca (8)Avalere LLC, (9)AbioMed, and(10) 1798 Consultants. Non-profit: Michael J. Fox Foundation.

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Panelist, and later (2010-2011) Vice-Chair CMS-Medcac (Medicare Evidence Development and Coverage Advisory Committee). For the duration of the Medcac meeting, usually 1-2 days, I was considered an SGE (Special Government Employee). I was a member of the AAN Payment Policy Subcommittee (PPS)from 2006 to 2011. Non-financial disclosures: I was asked in Jan. 2010 to advice and represent a device manufacturing company on preparing a response to AAN's position on TENS and back pain treatment. I spoke to them and declined their offer of a consulting fee or representation. My policy, written as a former Medicare Medical Director, concerning IVIg use in adults with immunodeficiency and HIV or AIDS became the subject of discord with one provider. This issue was also handled by CMS. It has not been active since 2005-6. This matter, even if it were active, is NOT THE subject of the current paper.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Joseph Lockhart, PhD, ABPP
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Traveling and lodging expenses, 2011, 2012, and 2013 from SAMHSA/NIDA for training and developing Veterans' Treatment Courts. No direct payments or honoraria.

    Editorial Boards:

    1. Editorial Advisory Board, Open Access Journal of Forensic Psychology. 2012-present. No compensation received.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Health Policy Consultant (SS-M), Santa Maria, CA; and Forensic Services Division (JL), California Department of State Hospitals, Sacramento.
  1. Correspondence to:
    josephjlockhart{at}gmail.com
View Full Text

Article usage

Article usage: September 2015 to December 2022

AbstractFullPdfSource
Sep 201515508Highwire
Oct 20156182040Highwire
Nov 20153236759Highwire
Dec 201515284Highwire
Jan 201610725Highwire
Feb 20165621Highwire
Mar 20165620Highwire
Apr 20163502Highwire
May 20166411Highwire
Jun 20162502Highwire
Jul 20162510Highwire
Aug 20163811Highwire
Sep 20163201Highwire
Oct 20163000Highwire
Nov 20163910Highwire
Dec 20161900Highwire
Jan 20172700Highwire
Feb 20172601Highwire
Mar 20172610Highwire
Apr 20172000Highwire
May 20174110Highwire
Jun 20171600Highwire
Jul 20173002Highwire
Aug 20171601Highwire
Sep 20171700Highwire
Oct 20174000Highwire
Nov 20172700Highwire
Dec 20172210Highwire
Jan 20183201Highwire
Feb 20184031Highwire
Mar 20183511Highwire
Apr 20185001Highwire
Apr 201841822pmc
May 20183900Highwire
Jun 20183501Highwire
Jun 201852121pmc
Jul 20184521Highwire
Aug 20182700Highwire
Aug 201875051pmc
Sep 20183002Highwire
Oct 20184300Highwire
Nov 20183930Highwire
Dec 20184000Highwire
Jan 20193501Highwire
Feb 20195400Highwire
Mar 20193611Highwire
Apr 20192652Highwire
May 20193102Highwire
Jun 20191901Highwire
Jul 20193212Highwire
Aug 20192701Highwire
Sep 20193512Highwire
Oct 20195202Highwire
Nov 20192211Highwire
Dec 20192200Highwire
Jan 20204701Highwire
Feb 20202700Highwire
Mar 20202402Highwire
Apr 20204214Highwire
May 20202500Highwire
Jun 20204400Highwire
Jul 20202310Highwire
Aug 20202530Highwire
Sep 20203611Highwire
Oct 20202601Highwire
Nov 20206601Highwire
Dec 20208301Highwire
Jan 20213710Highwire
Feb 20214303Highwire
Mar 20217201Highwire
Apr 20216312Highwire
May 20216021Highwire
Jun 20215710Highwire
Jul 20217202Highwire
Aug 20216303Highwire
Sep 20216410Highwire
Oct 20218022Highwire
Nov 20217211Highwire
Dec 20215433Highwire
Jan 20224200Highwire
Feb 20226821Highwire
Mar 20225200Highwire
Apr 202212400Highwire
May 202210805Highwire
Jun 20226321Highwire
Jul 20224901Highwire
Aug 20226511Highwire
Sep 20229334Highwire
Oct 202211813Highwire
Nov 202215012Highwire
Dec 202211721Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me